NCT02822599View on ClinicalTrials.gov

Human Fibrinogen Concentrate in Pediatric Cardiac Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 1, 2017

Primary Completion Date

August 26, 2019

Study Completion Date

December 24, 2020

Conditions
HypofibrinogenemiaAfibrinogenemiaBleeding Disorders
Interventions
DRUG

RiaStAP

To decrease post-operative bleeding volume.

DRUG

Saline

Placebo consisting of normal saline 0.9%

Trial Locations (2)

33155

Nickalus Children's Hospital f/k/a Miami Children's Hospital, Miami

Nicklaus Children's Hospital, Miami

All Listed Sponsors
lead

Nicklaus Children's Hospital f/k/a Miami Children's Hospital

OTHER

NCT02822599 - Human Fibrinogen Concentrate in Pediatric Cardiac Surgery | Biotech Hunter | Biotech Hunter